Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Nasopharyngeal Neoplasms × penpulimab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Carcinoma, Non-Small-Cell Lung 3 Stomach Neoplasms 2 Nasopharyngeal Carcinoma 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Lung Neoplasms 2 Carcinoma, Hepatocellular 2 Advanced Solid Tumor 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Rectal Neoplasms 1 Pheochromocytoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Paraganglioma, Extra-Adrenal 1 Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma Metastatic 1 Osteosarcoma 1 Neoplasms by Histologic Type 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma 1 Gynecological Cancer 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Esophageal Squamous Cell Carcinoma 1 Digestive System Diseases 1 Carcinoma, Squamous Cell 1

Interventions

Cisplatin 34 Gemcitabine 21 Fluorouracil 15 Radiotherapy 10 Docetaxel 9 pembrolizumab 8 Radiotherapy, Intensity-Modulated 8 Paclitaxel 8 Carboplatin 7 Capecitabine 6 Oxaliplatin 5 Bevacizumab 4 spartalizumab 3 camrelizumab 3 Surveys and Questionnaires 3 Induction Chemotherapy 3 Immunohistochemistry 3 Endostatins 3 Cetuximab 3 Acupuncture Therapy 3 toripalimab 2 tislelizumab 2 nimotuzumab 2 endostar protein 2 apatinib 2 Taxes 2 Psychiatric Rehabilitation 2 Polymerase Chain Reaction 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05807880 2026-01-23

ALTER-HN005

Sun Yat-sen University

Phase 2 Active not recruiting

Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡